Get started
Author

Muhammed Muhiddin Er

Observed names: Muhammed M. Er, Muhammed Muhiddin ER, Muhammed Muhittin Er, Muhiddin Er
ORCID: 0000-0002-0583-0295
Observed ORCID: 0000-0002-0583-0295
OpenAlex ID: A5069632206
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer
2023 · Seda Kahraman, Enes Erul, et al. · Future Oncology · 27
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases
2024 · Seda Kahraman, Serdar Karakaya, et al. · Scientific Reports · 20
Could the concomitant use of beta blockers with bevacizumab improve survival in metastatic colon cancer?
2023 · Mehmet Zahid Kocak, Muhiddin Er, et al. · European Journal of Clinical Pharmacology · 14
Ribociclib-induced hepatotoxicity
2023 · Muhammed Muhiddin Er, Murat Araz, et al. · Journal of Oncology Pharmacy Practice · 12
The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in the first line
2024 · Mustafa Korkmaz, Melek Karakurt Eryılmaz, et al. · European Journal of Clinical Pharmacology · 9
Prognostic Role of Inflammatory and Nutritional Indices in NSCLC Patients Treated with Immune Checkpoint Inhibitors: Retrospective, Multicenter, Turkish Oncology Group Study of Overall and Elderly Populations
2025 · Ozkan Alan, Tugba Akın Telli, et al. · Medicina · 8
PDF
Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
2025 · Seda Kahraman, Enes Erul, et al. · Clinical Breast Cancer · 7
Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study
2024 · Seda Kahraman, Mutlu Hizal, et al. · BMC Cancer · 6
PDF
Is the Prognostic Nutritional Index a Prognostic Marker for the Survival of Patients with Lymph-Node Positive Stage II-III Gastric Cancer Who Receive Adjuvant Chemotherapy?
2023 · Mustafa Korkmaz, Melek Karakurt Eryılmaz, et al. · Journal of Gastrointestinal Cancer · 6
Does red blood cell distribution width predict prognosis in metastatic renal cell carcinoma patients using first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy?
2023 · Mustafa Korkmaz, Melek K. Eryılmaz, et al. · Journal of Cancer Research and Therapeutics · 6
The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study
2023 · Muzaffer Uğraklı, Mehmet Zahid Koçak, et al. · Journal of Cancer Research and Clinical Oncology · 4
PDF
First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal carcinoma
2022 · Selin Aktürk Esen, Yakup Ergun, et al. · Bosnian Journal of Basic Medical Sciences · 4
Pazopanib-associated secondary adrenal insufficiency in a patient with malignant solitary fibrous tumor
2021 · Muhammed Muhiddin Er, Murat Araz, et al. · Journal of Oncology Pharmacy Practice · 2
The Impact of the COVID-19 Pandemic on Follow-Up and Management of Cancer Patients
2021 · Melek KARAKURT ERYILMAZ, Mustafa KARAAĞAÇ, et al. · Journal of Oncological Sciences · 2
PDF
HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy
2025 · Seda Kahraman, Mutlu Hızal, et al. · Turkish Journal of Clinics and Laboratory · 1
PDF
Konya İli̇ndeki̇ Eri̇şki̇n Çölyak Hastalarinin Epi̇demi̇yoloji̇k, Kli̇ni̇k Ve Laboratuvar Bulgularinin Retrospekti̇f Olarak Değerlendi̇ri̇lmesi̇
2021 · Muhammed Muhiddin ER, Ali DEMİR · Ege Tıp Bilimleri Dergisi · 1
PDF
Prognostic Impact of the Systemic Immune-Inflammation Index According to Concurrent Chemotherapy Backbone in Stage III Non-Small Cell Lung Cancer
2026 · Aykut Demirkıran, Murat Araz, et al. · Current Oncology
PDF
Early PSA Decline Predicts Survival Outcomes in Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors: A Retrospective Single-Center Study
2026 · Engin Hendem, Mehmet Zahid Koçak, et al. · Medicina
PDF
Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study
2026 · Özlem Özdemir, Damla Günenç, et al. · Journal of Clinical Medicine
The Efficiency of Concomitant Antibiotic Usage On Survival Outcomes of Nivolumab-Treated Metastatic Renal Cell Carcinoma Patients: A Multicenter Experience
2025 · Muzaffer Uğraklı, Mehmet Zahid Koçak, et al. · Research Square
Works count: 20
Citation count: 129
H-index: 7
I10-index: 4
Year
Topic
Type